Back to Sites MU-JHU Care Limited CRS Site Number 5126 Address MU-JHU Care Limited CRS Upper Mulago Hill Road P.O. BOX 23491 Kampala, Uganda IMPAACT Members at this Site Teopista Nakyanzi CAB Liaison Thamali Genga CAB Member Peter Mudiima CAB Member Deo Wabwire CRS Coordinator Philippa Musoke CRS Leader Clemensia Nakabiito CRS Leader Abbey Kafumbe CRS Staff Christine Kizza CRS Staff Joyce Matovu CRS Staff Rosemary Namwanje CRS Staff Christopher Ndugwa CRS Staff Edith Oluka CRS Staff Henry Tumwijukye CRS Staff Mary Glenn Fowler CTU Principal Investigator Sue Welsch DAIDS PO Danstan Bagenda Data Manager Mike Mubiru Data Manager Winnie Nansamba Data Manager Joseph Ouma Data Manager Airene Dasal Director Charles Gabula Financial Administrator Linda Barlow-Mosha Investigator Monica Etima Investigator Brenda Kateera Investigator Kenneth Kintu Investigator Irene Lubega Investigator Mahnaz Motevalli-Oliner Investigator Nataliya Nyombi Investigator Maxensia Owor Investigator Lilian Wambuzi Investigator Eric Wobudeya Investigator Ronald Wasswa Laboratory Technician/Technologist Ali Elbireer Local Laboratory Pontiano Kaleebu Local Laboratory Isaac Ssewanayana Local Laboratory Hellen Kaganzi Medical Officer Juliane Etima N/A Judith Mbanza N/A Mark Ssenyonga Pharmacist Brenda Kakayi Pharmacist of Record Rebecca Sakwa Pharmacist of Record Enid Kabugho Protocol Coordinator Agnes Naggirinya Protocol Coordinator Dorothy Sebikari Protocol Coordinator Victoria Chou Regulatory Coordinator Joshua Kagoda Regulatory Coordinator Maria Musisi Regulatory Coordinator Paula Namayanja Regulatory Coordinator Constance Namirembe Regulatory Coordinator Neiksha Stephens Regulatory Coordinator Jim Aizire Study Coordinator Moreen Kamateeka Study Coordinator Hajira Kataike Study Coordinator Phionah Kibalama M.D. Study Coordinator Joel Maena Study Coordinator Prossy Nakanwagi Study Coordinator Joselyne Nansimbe Study Coordinator Sawsan Osman Study Coordinator Studies at this Site P1026S: PK in Pregnancy DAIDS Number Therapeutics Research Area Treatment Study Status Closed to Follow Up P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT DAIDS Number 10166 Research Area Treatment Study Status Concluded P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Therapeutics Study Status Concluded P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed Pagination Current page 1 Page 2 Next page Next
P1026S: PK in Pregnancy DAIDS Number Therapeutics Research Area Treatment Study Status Closed to Follow Up
P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT DAIDS Number 10166 Research Area Treatment Study Status Concluded
P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded
P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Concluded
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis
P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up
P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Therapeutics Study Status Concluded
P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Therapeutics
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed